A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims. Photo by Adobe Stock ...

Current vial sizes may result in 5.8% of the Alzheimer's disease drug being thrown away, representing $1,619 in wasted Medicare spending per patient per year, reported researchers led by John Mafi ...

A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims. Photo by Adobe Stock/HealthDay ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Current lecanemab vial sizes lead to 5.8% waste, a study suggested. An estimated $133 million to $336 million worth of ...

“Modifying vial sizes to reduce discarded doses is penny wise, but ultimately widespread coverage by Medicare may be pound foolish considering the limited potential for benefit, the substantial ...

14, 2024 (HealthDay News) -- A simple tweak in available vial sizes of the breakthrough Alzheimer’s drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims.

The PEG 400 load from concomitant medications should be taken into consideration when prescribing Tepylute. Both vial sizes are now available, according to Shorla Oncology.